- The main contract of Nymex crude oil futures has just broken through the $81.00 per barrel mark, now quoted at $80.95 per barrel, down 2.79% for the day.
- M&G lifts Bilfinger voting rights to 3.26% from 3.09%
- Saga Communications Q2 revenue falls 6.5% on higher expenses
- Syquant Capital adds to Exail Technologies long CFD position at EUR 124.6, holding 118,595 CFDs
- Boussard & Gavaudan raises long CFD position in Fnac Darty to 325,547 at EUR 34.55
- StandardAero signs exclusive multi-year PW127M MRO contract with Precision Air
- AIR CANADA : UBS RAISES TARGET PRICE TO C$33 FROM C$24
- Fitzroy Minerals identifies multiple deep IP anomalies at Caballos copper project in Chile
- CrowdStrike expands Project QuiltWorks to SMB market via global channel partners
- Fed’s Harker recently stated: “The two recent inflation reports are encouraging, but we cannot be certain that inflation will continue to improve in this direction. Americans are facing real pressure from inflation. In addition to inflation, we also need to pay attention to private credit and whether there is a bubble in artificial intelligence. There is also noise in the employment data. Currently, a large amount of leverage is being used to purchase Treasury bonds, so Treasuries are an area I
- Federal Reserve's Harker: Americans are facing real pressure from inflation.
- Nucor to invest $59 million to expand Vulcraft Indiana plant, add steel grating production
- Renforth Resources targets up to $1 million private placement of flow-through shares, units
- Goldman Sachs lifts CECONOMY voting rights to 5.97% from 4.94%
- Goldman Sachs holds 5.15% stake in Alstom
- Webdyn buys 16 Adeunis shares at EUR 0.84 during tender offer
- Semperit management board member Manfred Stanek buys 3,200 shares at EUR 15.4 each
- Roche Might Revise Diagnostics Midterm Sales Target After Product Launches, Unit CEO Says
- bioAffinity Technologies prices USD 4 million private placement at USD 0.47 per share unit
- Possibility of Faster BOJ Rate Rises Won't Help Yen on Its Own -- Market Talk
- Demant director Thomas Hofman-Bang buys shares worth DKK 4.97 million
- CMX Gold & Silver appoints Rick Walker as VP exploration
- NASDAQ TRADE HALT CONTINUES <TBCVU.O> REASON NOT AVAILABLE AT 09:05 AM
- Parker Hannifin completes acquisition of Filtration Group Corp
- Arizona Gold & Silver hits 21.79 meters at 4.1 g/t gold at Philadelphia project in Arizona
- TerraVest FY26 Q3 net income more than doubled to $35,604; sales rise 14% to $460,894
- Interlink Electronics Q2 FY26 net income rises to $248,000; revenue increases 10% to $3.77 million
- Janus Henderson cuts Bike24 voting rights stake to 0% from 7.83%
- T. Rowe Price names Agrawal to lead expanded Investment AI Solutions unit
- Thunderstruck Resources prices non-brokered private placement at $0.15/share to raise $1.8 million
- STAAR SURGICAL COMPANY <STAA.O>: UBS CUTS TARGET PRICE TO $19 FROM $20
- ACCENDRA HEALTH INC : UBS CUTS TARGET PRICE TO $1.5 FROM $4.5
- XYLEM INC <XYL.N>: UBS RAISES TARGET PRICE TO $138 FROM $135
- PACKAGING CORP OF AMERICA : UBS RAISES TARGET PRICE TO $292 FROM $271
- KONTOOR BRANDS, INC. <KTB.N>: UBS RAISES TARGET PRICE TO $136 FROM $131
- JACK IN THE BOX INC <JACK.O>: UBS RAISES TARGET PRICE TO $20 FROM $14
- ASSURANT INC : UBS RAISES TARGET PRICE TO $331 FROM $274
- CISCO SYSTEMS INC <CSCO.O>: UBS RAISES TARGET PRICE TO $138 FROM $132
- BRINKER INTERNATIONAL INC <EAT.N>: UBS RAISES TARGET PRICE TO $285 FROM $260
- GOODRX HOLDINGS, INC. <GDRX.O>: UBS RAISES TARGET PRICE TO $3.75 FROM $2.5
- RMX net loss more than doubles to USD 11.05 million in Q2 FY26; revenue drops 89% to USD 1,440
- BRP to host Q2 FY2027 results conference call
- TerraVest declares quarterly dividend of $0.20 per share
- OptimumBank raises annual EPS outlook to about $1-$1.15
- Cyabra Q2 FY26 net loss widens 41% to USD 3.44 million; revenue rises 39% to USD 1.85 million
- Silver Hammer completes 2026 surface exploration program at Eliza silver project in Nevada
- Emerson wins multi-million-dollar BP Shah Deniz Compression automation contract
- Qualstar Q2 FY26 net loss widens to $1.1 million; revenue rises 47% to $2.1 million
- Marsh McLennan’s Mercer forms strategic alliance with Compa on AI-driven compensation insights
- HCA’s Sarah Cannon Research Institute partners with Merck to expand access to oncology clinical trials in US communities
- Clutter by Iron Mountain relaunches premium managed personal storage service
- Comstock Q2 FY26 net income more than doubled to $8.85 million; revenue rises 74% to $22.58 million
- Credit Acceptance names ex-Amazon AI executive Jeetu Mirchandani as CTO
- nCino partners with Dun & Bradstreet to integrate D&B Commercial Graph into client lifecycle management platform
- Lifeway Foods 2Q Net $127,000 >LWAY
- BRINKER INTERNATIONAL INC <EAT.N>: JP MORGAN RAISES TARGET PRICE TO $250 FROM $190
- Lifeway Foods Q2 FY26 net income turns to USD 0.1 million; net sales rise 24.1% to USD 66.9 million
- MongoDB partners with Voyage AI to power automated embeddings on Atlas
- Market pricing indicates that bets on the Federal Reserve keeping rates unchanged in September have increased. The probability of the Federal Reserve maintaining rates in the 3.50%-3.75% range in September is around 65%, up from about 60% before the release of the PPI report.
- Parker Completes Acquisition Of Filtration Group Corporation >PH
- NASDAQ TRADE HALT CONTINUES <SVA.O> REASON NOT AVAILABLE AT 09:00 AM
- NASDAQ TRADE HALT CONTINUES <QMMM.O> REASON NOT AVAILABLE AT 09:00 AM
- NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
- Lifeway Foods 2Q EPS 1c >LWAY
- Interlink Electronics 2Q Rev $3.77M >LINK
- Dow Jones Top Markets Headlines at 9 AM ET: U.S. Producer-Price Index Unchanged in July | U.S. ...
- NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM
- Saga Communications 2Q EPS 15c >SGA
- Saga Communications 2Q Net $960,000 >SGA
- Saga Communications 2Q Rev $26.4M >SGA
- CARRIAGE SERVICES INC <CSV.N>: OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING AND TARGET PRICE $48
- Federal Reserve official Harker recently stated: "The Fed must raise interest rates now because current policy is not restrictive, and recent shocks have driven inflation higher. Rapid growth could put additional pressure on prices. Raising rates may be painful, but we cannot allow economic growth and investment to become excessive to the point where the economy overheats. Current inflation is widespread and not limited to just certain sectors. The Fed must be accountable for inflation data, an
- Goldcana Resources announces 2-for-1 stock split, shares to double to 22,536,000
- CSN Mineracao posts 2Q26 net income of R$ 219 million, up 89% y/y
- Boa Acquisition Corp II units to split into Nasdaq-listed shares, rights on Aug. 14
- Yue Ying: August 13 Bitcoin and Ethereum Market Analysis - Continue to Wait for Direction at a Slow Pace, Short-term Strategies Included
- Frontier Lithium proposes amendments to $3.35 million convertible loan, extends maturity 18 months
- BRIEF-Biofrontera Q2 Revenue USD 12 Million
- Biofrontera 2Q Loss/Shr 5c >BFRI
- Federal Reserve's Barkin: Employment continues to support household consumption, while those who own real estate or stocks have enjoyed "significant" wealth growth.
- Biofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million
- Federal Reserve's Barkin: Given that compensation pressure is moderate, and tariffs, oil, and other shocks may subside, there is sufficient reason to believe that inflation will ease.
- Federal Reserve's Harker: The Fed must be accountable to a single inflation data point, and this is very important.
- BRIEF-Frontier Lithium Announces Proposed Amendments To Convertible Loan
- Solstad Maritime signs LOI for Normand Cutter subsea support contract starting late 2026/early 2027
- Novus lifts Mustek stake to 56.86% in voting rights disclosure
- Ategrity Specialty Q2 FY26 net income attributable to stockholders rises 89.8% to $33.45 million
- ADC Therapeutics posts corporate presentation highlighting Zynlonta growth opportunity in B-cell lymphomas
- OS Therapies wins FDA Type C meeting to review 2.5-year survival data for OST-HER2 Phase 2b osteosarcoma trial
- BRIEF-Orbit International Q2 EPS USD -0.51
- Copel declares BRL 706 million interest on equity, payable Sept. 30
- KOIL Energy Q2 FY26 net income rises to $652,000; revenue climbs 78% to $9.2 million
- Orbit International Q2 FY26 net loss widens to $1.72 million; net sales fall to $4.89 million
- Dogwood Therapeutics: Halneuron Phase 2b Trial in Chemotherapy Induced Neuropathy on Track for Top-Line Results in Fall 2026, 217 Patients Enrolled >DWTX
- Innovative Solutions 3Q Sales $26.7M >ISSC
- Fate Therapeutics 2Q Loss/Shr 25c >FATE
- What makes a good crypto trader? — AMA recap with Paradyze
- Bitcoin Dominance Remains Overdue for a Huge Decline as Altcoin Market Undergoes a Massive Reset
- SEC allows Franklin Templeton funds to invest in onchain money fund
- Robinhood Chain posts $1.05 million in 24-hour NFT trading volume
